Drug Shortage Report for TEVA-MEDROXYPROGESTERONE
Report ID | 99938 |
Drug Identification Number | 02221306 |
Brand name | TEVA-MEDROXYPROGESTERONE |
Common or Proper name | MEDROXYPROGESTERONE 10MG TABS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | MEDROXYPROGESTERONE ACETATE |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | G03DA |
ATC description | PROGESTOGENS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-11-28 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2021-10-14 |
Company comments | Item is on suspended supply |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-11-28 | English | Compare |
v2 | 2019-11-28 | French | Compare |
v3 | 2019-11-29 | English | Compare |
v4 | 2020-01-09 | English | Compare |
v5 | 2020-01-09 | French | Compare |
v6 | 2020-02-07 | English | Compare |
v7 | 2020-02-07 | French | Compare |
v8 | 2020-06-04 | English | Compare |
v9 | 2020-06-04 | French | Compare |
v10 | 2020-07-16 | English | Compare |
v11 | 2020-07-16 | French | Compare |
v12 | 2020-08-20 | English | Compare |
v13 | 2020-08-20 | French | Compare |
v14 | 2020-09-03 | English | Compare |
v15 | 2020-09-03 | French | Compare |
v16 | 2021-03-25 | English | Compare |
v17 | 2021-03-25 | French | Compare |
v18 | 2021-08-24 | English | Compare |
v19 | 2021-08-24 | French | Compare |
v20 | 2021-10-14 | English | Compare |